Supplementation with a probiotic blend appears to support children’s immune function by encouraging an anti-inflammatory response that could help reduce the symptoms characterising respiratory infection.
International Flavors & Fragrances Inc (IFF) and DuPont’s Nutrition & Biosciences (“N&B”) completed their €40.7bn merger yesterday (February 1st) and revealed a modernised identity for the new industry giant.
DuPont Nutrition & Biosciences has launched HOWARU Calm, a probiotic aimed at helping dietary supplement manufacturers decrease the cycle of consumer stress.
A DuPont review has reinforced the link between the gut microbiome and sporting performance as the firm’s researchers identify probiotics’ role in training support, performance, and post-exercise recovery.
DuPont’s Human Microbiome Venture is to partner up with Procter & Gamble (P&G) in a new research agreement that looks into how probiotics can be used to address metabolic health conditions.
DuPont’s Human Microbiome Venture (HMV) continues to go from strength to strength as the US bio-based company forms a research collaboration with Rutgers University.
Human Milk Oligosaccharides (HMO) such as 2’-fucosyllactose (2’-FL), and galactooligosaccharides (GOS) that are added to infant formula may offer protection against bacterium known to cause tooth decay.
DuPont Nutrition & Biosciences and APC Microbiome Ireland further strengthen their existing partnership with a new collaborative project looking into rebalancing babies’ gut bacteria.
DuPont Nutrition & Biosciences are to enter another microbiome-related collaboration, this time with MRM Health, in a biotherapeutic-themed pact that looks to address a number of metabolic conditions.
A mega-merger between International Flavors & Fragrances Inc (IFF) and DuPont nutrition & biosciences unit will create a new industry giant worth more than $45 billion (€40.4 billion), say those involved in the deal.
DuPont Nutrition & Biosciences are to partner with TED Talks to present a series of sustainability-related sessions that discuss among other topics, the infant gut microbiota role on health in later life.
A DuPont-led study outlines 2’-fucosyllactose’s (2’-FL) beneficial effect on the infant gut compared to galacto-oligosaccharides (GOS) and lactose as a team identify the oligosaccharide as a first choice energy source for selected infant microbes.
DuPont Nutrition and Chinese supplement giant BY-HEALTH will collaborate to develop probiotics with new functions, including anti-ageing, oral and skin health.
The ingredients manufacturer has launched a stabiliser made from fermented bio-based raw materials that caters to the surging plant-based trend, DuPont tells FoodNavigator.
Responding to the need for strain-specific probiotic testing, Eurofins becomes the first third party laboratory to employ DuPont’s polymerase-chain-reaction (PCR) genotyping assays to identify probiotics at the strain level.
The European Commission (EC) has conditionally cleared a two-way deal acquisition between FMC and DuPont, based on promises that both companies will divest parts of their existing business.
DuPont’s nutrition & health president, Matthias Heinzel, tells NutraIngredients his multi-billion euro division wants to speed product-to-market time and is “totally open” to working with start-ups in open collaboration.
DuPont is reaping the benefit of its €5bn 2011 acquisition of Danish probiotics and enzymes giant Danisco, with its nutrition and health division showing 23% profit growth in a “sluggish” world market.
As we move forward into the year’s second semester, NutraIngredients looks back at two major acquisitions – DSM’s buy-out of Martek, and DuPont’s purchase of Danisco.
DSM has tendered its 4.95 per cent stake in Danish ingredients firm Danisco, after buyer DuPont raised its offer to DKK700 on Friday following discussions with major shareholders.
Danisco’s fine Q3 results may make some investors less willing to sell, believing the company can bring profit alone or that DuPont may be persuaded to raise its offer, say commentators.
DuPont would look to move its food ingredients R&D to Denmark following its acquisition of Danisco, and adopt the latter’s Sales and Application development organisation to get ingredients to market, offer documents reveal.
Danisco is to be snapped up by DuPont for $6.3bn, in a deal Dupont says could create a global leader in industrial biotech – and help drive science-based solutions to the world’s food and fuel challenges.
